Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phenylephrine, Norepinephrine and Vasopressin on Cerebral Oxygenation During Off Pump CABG
NCT04214145Completed
- Sponsor
- Seoul National University Hospital
- Start
- Jan 2020
- Primary completion
- Sep 2021
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Trial of phenylephrine, norepinephrine and vasopressin in hypotension (3 arms), sponsored by Seoul National University Hospital. Primary endpoint: Cerebral oxygen saturation. Started Jan 2020; status: completed.
02
Drugs
phenylephrinenorepinephrinevasopressin
03
Conditions
hypotension
Beyond the preview
Go deeper on NCT04214145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04214145.